CHRNG Antibody - N-terminal region
Catalog Number:
ASB-AVARP13024_P050
- Images (4)
| Article Name: | CHRNG Antibody - N-terminal region |
| Biozol Catalog Number: | ASB-AVARP13024_P050 |
| Supplier Catalog Number: | AVARP13024_P050 |
| Alternative Catalog Number: | ASB-AVARP13024_P050-25UL,ASB-AVARP13024_P050-100UL |
| Manufacturer: | Aviva |
| Host: | Rabbit |
| Category: | Proteine/Peptide |
| Application: | WB |
| Species Reactivity: | Bovine, Canine, Guinea pig, Human, Mouse, Rabbit, Rat |
| Immunogen: | The immunogen is a synthetic peptide directed towards the N terminal region of human CHRNG |
| Alternative Names: | ACHRG |
| For background information on the acetylcholine receptor (AChR), see CHRNA1. Two forms of AChR are found in mammalian skeletal muscle cells. The mature form is predominant in innervated adult muscle and the embryonic form is present in fetal and denervated muscle. Embryonic and mature AChR differ by the replacement of the gamma subunit in the pentameric glycoprotein complex by its isoform, the epsilon subunit, which is specific to the mature AChR subtype. This switch is mediated by ARIA (acetylcholine receptor-inducing activity.For background information on the acetylcholine receptor (AChR), see CHRNA1 (MIM 100690). Two forms of AChR are found in mammalian skeletal muscle cells. The mature form is predominant in innervated adult muscle and the embryonic form is present in fetal and denervated muscle. Embryonic and mature AChR differ by the replacement of the gamma subunit in the pentameric glycoprotein complex by its isoform, the epsilon subunit (MIM 100725), which is specific to the mature AChR subtype. This switch is mediated by ARIA (acetylcholine receptor-inducing activity, MIM 142445).[supplied by OMIM]. PRIMARYREFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP 1-2187 AK125362.1 1-2187 |
|
|
WB Suggested Anti-CHRNG Antibody Titration: 1 ug/ml Positive Control: MCF7 Whole Cell |
|
|
25 ug of the indicated Human whole cell or tissue extracts was loaded onto a 12% SDS-PAGE gel. 3 ug/mL of the antibody was used in this experiment. Protein is processed to 55 kDa and may be glycosylated. |
|
|
25 ug of the indicated Human whole cell or tissue extracts was loaded onto a 12% SDS-PAGE gel. 3 ug/mL of the antibody was used in this experiment.The peptide is also contained within a 52 kDa isoform. Protein may be glycosylated. |
|
|
CHRNG antibody - N-terminal region (AVARP13024_P050) in Human MCF-7 using Western Blot |
Product Guarantee and Expert Support
